2,7-Dibromo-9-(tridecan-7-ylidene)-9H-fluorene, 98%, 1g

ethyl 6-Bromo-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylate, 96%, 100mg

Ácido 2-etilhexanoico 250mL, >=99%, para síntesis, 250mL, envase de vidrio

1-Methyl-3,4-dinitro-1H-pyrazole, 2g

5-BROMO-1,2,3-TRIS(DODECYLOXY)BENZENE, 95%, 1g

gamma-Nonanolactone>98.0%(GC)25mL

(R)-1-(5-FLUORO-2-METHOXYPYRIDIN-3-YL)ETHAN-1-AMINE, 95%, 100mg

1H-Imidazol-2-ylmethanol, 95.0%, 5g

1-(2-METHYLPHENYL)CYCLOBUTANE-1-CARBOXYLIC ACID, 95.0%, 500mg

methyl 1-(2-methoxyethyl)-1H-pyrazole-5-carboxylate, 95.0%, 100mg

2,4-Dichloropyrimidine-5-carboxamide, 95.0%, 100g

2-(2,5-Dibromophenoxy)ethanol, 95+%, 250mg

2,4-Dimethyl-1H-imidazole-5-carbaldehyde, 95.0%, 100mg